|
Avastin slows progress of breast cancer in trial
The addition of Genentech Inc's cancer drug Avastin to chemotherapyslows the progress of breast cancer at two different doses,according to results of a large international trial released onSaturday.
More... |
| All times are GMT -7. The time now is 11:59 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021